Trials Offered by a Specific Doctor

HERBERT IRVING COMPREHENSIVE CANCER CENTER
Investigator
Nicole Lamanna, MD
Email
nl2129@cumc.columbia.edu

Nicole Lamanna, MD, is an Associate Clinical Professor of Medicine in the Hematologic Malignancies Section of the Hematology/Oncology Division. Dr. Lamanna is a hematologist/oncologist whose research interests include lymphoid leukemias, specifically chronic lymphocytic leukemia.

She is an experienced clinical investigator and her research focus has been the development of combination therapies that include chemoimmunotherapy, immunomodulatory drugs, novel kinase inhibitors and monoclonal antibodies. She also is working to find active, safer therapies for older patients with these diseases.

She earned her medical degree from Albert Einstein College of Medicine and completed her fellowship in Hematology-Oncology at Memorial Sloan-Kettering Cancer Center.


Clinical Studies Managed By Dr. Lamanna:
More InfoTitleSponsorIRB Number
Details[CLOSED] A study for subjects with chronic lymphocytic leukemia using study drug ABT-199AbbVieAAAN9606
Details[CLOSED] A study for patients with Richter's Transformation (RT) using study drug PNT2258Pronai TherapeuticsAAAP4516
Details[CLOSED] A study for patients Chronic Lymphocytic Leukemia using study drug BI 836826Gilead Sciences, IncAAAQ4712
Details[CLOSED] A study for patients with Leukemia using study drug acalabrutinibAcerta PharmaAAAQ4711
Details[CLOSED] A study for patients with chronic lymphocytic leukemia (CLL) using study drug TDR-1202TG TherapeuticsAAAQ8698
Details[CLOSED] A study for patients with solid tumors or lymphoma using study drug LY3039478Eli Lilly and CompanyAAAQ7203
Details[CLOSED] Study of Drug in Patients with Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaBeiGene, Ltd.AAAR6732
DetailsStudy of Drug in Patients with B-Cell Lymphoid MalignanciesOncternal TherapeuticsAAAR5429
Details[CLOSED] Study of Drug in Patients with Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)Verastem, Inc.AAAR6847
DetailsStudy of JCAR017 in Subjects with Lymphocytic Leukemia or Small Lymphocytic LymphomaJuno TherapeuticsAAAR6134
DetailsStudy of Bendamustine/Rituximab Induction Followed by Venetoclax and Rituximab Consolidation for Treatment of Chronic Lymphocytic LeukemiaAbbVieAAAR6357
DetailsA Study of MS-553 in Patients with Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)MindSight Pharmaceuticals, Inc.AAAR9532
DetailsA Study of Zanubrutinib (BGB-3111) Versus Ibrutinib in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia (ALPINE)BeiGene, Ltd.AAAS2723
DetailsLOXO-305 in Patients With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkins LymphomaLoxo Oncology, Inc.AAAS3311
DetailsStudy of Acalabrutinib (ACP-196) in Combination with Venetoclax with and without Obinutuzumab in Subjects with Chronic Lymphocytic LeukemiaAcerta Pharma BVAAAS5165